The backstory, briefly: for over two decades, estrogen-based hormone therapy sat in a kind of medical purgatory. A 2002 Women's Health Initiative study raised alarms about breast cancer and heart disease risk, the FDA attached a black-box warning, and millions of women either never started or quietly stopped. Use fell below 5%. A generation of doctors became hesitant. A generation of women suffered.
Then the re-evaluation happened. More rigorous analysis made clear the original study had serious flaws — it used specific formulations, in older populations, in ways that couldn't be generalized to all HRT for all women. Last July, FDA Commissioner Marty Makary began publicly calling the therapy potentially "lifesaving." In November, the black-box warning was removed. And demand exploded: estrogen patch use is up 184% since 2023, with a 26% jump in prescriptions in the two months following the November announcement alone.
The problem is that estrogen patches are generic drugs. Low profit margins. No incentive for manufacturers to rush expensive new production infrastructure. And now: a shortage that industry sources say could last up to three years. Women are hunting across multiple pharmacies, switching formulations midstream, or going without. Stopping abruptly can bring symptoms roaring back. Switching products can bring new side effects.
What's actually useful to know: If you use patches and you're having trouble filling your prescription, you're not alone and it's not a local fluke. Call ahead before going to the pharmacy. Ask your prescriber about alternative delivery forms — gels, sprays, rings — which aren't facing the same shortages. Telehealth platforms with compounding pharmacies have been adding supply to meet demand, though compounded versions aren't FDA-reviewed as finished products, so ask your doctor what that means for you specifically.
And if someone tells you patches are the only "right" way to take HRT, it's worth a second opinion — individualized therapy matters here.
What deserves caution: A few things are getting conflated in the social media churn around this story. Not every woman needs HRT. Not every woman who wants it is a candidate. The rush toward one-size-fits-all prescribing — sparked partly by celebrities and influencers and partly by doctors who aren't menopause specialists — is a real concern raised by clinicians this week. The cultural rehabilitation of HRT is largely warranted. The hype machine around it is not.
Read more: NBC News →
